ArticleBreast cancer research and treatment2017

Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.

Muhammad Asaduzzaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.